{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Coronavirus disease 2019 (COVID-19)", "Indian traditional medicine", "Mechanism of action", "SARS-CoV-2", "Therapeutic approach"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "32278175", "DateCompleted": {"Year": "2020", "Month": "06", "Day": "01"}, "DateRevised": {"Year": "2023", "Month": "11", "Day": "13"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "04", "Day": "04"}], "Language": ["eng"], "ELocationID": ["10.1016/j.scitotenv.2020.138277", "S0048-9697(20)31790-3"], "Journal": {"ISSN": "1879-1026", "JournalIssue": {"Volume": "725", "PubDate": {"Year": "2020", "Month": "Jul", "Day": "10"}}, "Title": "The Science of the total environment", "ISOAbbreviation": "Sci Total Environ"}, "ArticleTitle": "COVID-19: A promising cure for the global panic.", "Pagination": {"StartPage": "138277", "MedlinePgn": "138277"}, "Abstract": {"AbstractText": ["The novel Coronavirus disease 2019 (COVID-19) is caused by SARS-CoV-2, which is the causative agent of a potentially fatal disease that is of great global public health concern. The outbreak of COVID-19 is wreaking havoc worldwide due to inadequate risk assessment regarding the urgency of the situation. The COVID-19 pandemic has entered a dangerous new phase. When compared with SARS and MERS, COVID-19 has spread more rapidly, due to increased globalization and adaptation of the virus in every environment. Slowing the spread of the COVID-19 cases will significantly reduce the strain on the healthcare system of the country by limiting the number of people who are severely sick by COVID-19 and need hospital care. Hence, the recent outburst of COVID-19 highlights an urgent need for therapeutics targeting SARS-CoV-2. Here, we have discussed the structure of virus; varying symptoms among COVID-19, SARS, MERS and common flu; the probable mechanism behind the infection and its immune response. Further, the current treatment options, drugs available, ongoing trials and recent diagnostics for COVID-19 have been discussed. We suggest traditional Indian medicinal plants as possible novel therapeutic approaches, exclusively targeting SARS-CoV-2 and its pathways."], "CopyrightInformation": "Copyright \u00a9 2020 Elsevier B.V. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Human Molecular Cytogenetics and Stem Cell Laboratory, Department of Human Genetics and Molecular Biology, Bharathiar University, Coimbatore 641 046, Tamil Nadu, India. Electronic address: geneticbala@buc.edu.in."}], "LastName": "Vellingiri", "ForeName": "Balachandar", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Zoology, Avinashilingam Institute for Home Science and Higher Education for Women, Coimbatore 641 043, Tamil Nadu, India."}], "LastName": "Jayaramayya", "ForeName": "Kaavya", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Zoology, Avinashilingam Institute for Home Science and Higher Education for Women, Coimbatore 641 043, Tamil Nadu, India."}], "LastName": "Iyer", "ForeName": "Mahalaxmi", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Disease Proteomics Laboratory, Department of Zoology, Bharathiar University, Coimbatore 641 046, Tamil Nadu, India."}], "LastName": "Narayanasamy", "ForeName": "Arul", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Farmer's Bio Fertilizers and Organics, Coimbatore 641 029, Tamil Nadu, India."}], "LastName": "Govindasamy", "ForeName": "Vivekanandhan", "Initials": "V"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Virology Laboratory, Central Research and Development Wing, Sree Balaji Medical College and Hospital (SBMCH), Bharath University, (BIHER), Chromepet, Chennai 600044, Tamil Nadu, India; Department of Forest Science, Central University of Nagaland, Lumami, Zunhebeto, India."}], "LastName": "Giridharan", "ForeName": "Bupesh", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Zoology, Thiruvalluvar University, Vellore 632115, India."}], "LastName": "Ganesan", "ForeName": "Singaravelu", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Human Molecular Cytogenetics and Stem Cell Laboratory, Department of Human Genetics and Molecular Biology, Bharathiar University, Coimbatore 641 046, Tamil Nadu, India."}], "LastName": "Venugopal", "ForeName": "Anila", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Human Molecular Cytogenetics and Stem Cell Laboratory, Department of Human Genetics and Molecular Biology, Bharathiar University, Coimbatore 641 046, Tamil Nadu, India."}], "LastName": "Venkatesan", "ForeName": "Dhivya", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Human Molecular Cytogenetics and Stem Cell Laboratory, Department of Human Genetics and Molecular Biology, Bharathiar University, Coimbatore 641 046, Tamil Nadu, India."}], "LastName": "Ganesan", "ForeName": "Harsha", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Human Molecular Cytogenetics and Stem Cell Laboratory, Department of Human Genetics and Molecular Biology, Bharathiar University, Coimbatore 641 046, Tamil Nadu, India."}], "LastName": "Rajagopalan", "ForeName": "Kamarajan", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Deploy Lead - Centre for Enzyme Innovation, Office No: 6.06, King Henry Building School of Biological Science, University of Portsmouth, Portsmouth PO1 2DY, UK."}], "LastName": "Rahman", "ForeName": "Pattanathu K S M", "Initials": "PKSM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Stem Cell and Regenerative Biotechnology, Konkuk University, Seoul, South Korea."}], "LastName": "Cho", "ForeName": "Ssang-Goo", "Initials": "SG"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology, Mizoram University (A Central University), Aizawl 796 004, Mizoram, India."}], "LastName": "Kumar", "ForeName": "Nachimuthu Senthil", "Initials": "NS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Genetics and Molecular Biology, Vision Research Foundation, Chennai 600 006, India."}], "LastName": "Subramaniam", "ForeName": "Mohana Devi", "Initials": "MD"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Sci Total Environ", "NlmUniqueID": "0330500", "ISSNLinking": "0048-9697"}, "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Betacoronavirus"}, {"QualifierName": [], "DescriptorName": "COVID-19"}, {"QualifierName": [], "DescriptorName": "Coronavirus Infections"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Pandemics"}, {"QualifierName": [], "DescriptorName": "Pneumonia, Viral"}, {"QualifierName": [], "DescriptorName": "SARS-CoV-2"}], "CoiStatement": "Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Agostini M.L., Andres E.L., Sims A.C., Graham R.L., Sheahan T.P., Lu X., Ray A.S. Coronavirus susceptibility to the antiviral remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease. MBio. 2018;9(2) doi: 10.1128/mBio.00221-18.", "ArticleIdList": ["10.1128/mBio.00221-18", "PMC5844999", "29511076"]}, {"Citation": "Akamatsu H., Komura J., Asada Y., Niwa Y. Mechanism of anti-inflammatory action of glycyrrhizin: effect on neutrophil functions including reactive oxygen species generation. Planta Med. 1991;57:119\u2013121. doi: 10.1055/s-2006-960045.", "ArticleIdList": ["10.1055/s-2006-960045", "1891493"]}, {"Citation": "Akram M., Tahir I.M., Shah S.M.A., Mahmood Z., Altaf A., Ahmad K., Munir N., Daniyal M., Nasir S., Mehboob H. Antiviral potential of medicinal plants against HIV, HSV, influenza, hepatitis, and coxsackievirus: a systematic review. Phytother. Res. 2018;32:811\u2013822. doi: 10.1002/ptr.6024.", "ArticleIdList": ["10.1002/ptr.6024", "29356205"]}, {"Citation": "Alam G., Wahyuono S., Ganjar I.G., Hakim L., Timmerman H., Verpoorte R. Tracheospasmolytic activity of viteosin-A and vitexicarpin isolated from Vitex trifolia. Planta Med. 2002;68:1047\u20131049. doi: 10.1055/s-2002-35650.", "ArticleIdList": ["10.1055/s-2002-35650", "12451502"]}, {"Citation": "Amber R., Adnan M., Tariq A., Mussarat S. A review on antiviral activity of the Himalayan medicinal plants traditionally used to treat bronchitis and related symptoms. J. Pharm. Pharmacol. 2017;69:109\u2013122. doi: 10.1111/jphp.12669.", "ArticleIdList": ["10.1111/jphp.12669", "PMC7166987", "27905101"]}, {"Citation": "American Society of Microbiology 2020. https://asm.org/PressReleases/2020/COVID-19-Resources"}, {"Citation": "Angeletti S., Benvenuto D., Bianchi M., Giovanetti M., Pascarella S., Ciccozzi M. COVID-2019: the role of the nsp2 and nsp3 in its pathogenesis. J. Med. Virol. 2020;2020:1\u20135. doi: 10.1002/jmv.25719.", "ArticleIdList": ["10.1002/jmv.25719", "PMC7228367", "32083328"]}, {"Citation": "Arora R., Chawla R., Marwah R., Arora P., Sharma R., Kaushik V., Goel R., Kaur A., Silambarasan M., Tripathi R. Potential of complementary and alternative medicine in preventive management of novel H1N1 flu (Swine flu) pandemic: thwarting potential disasters in the bud. Evid. Based Complement. Alternat. Med. 2011;2011:1\u201316. doi: 10.1155/2011/586506.", "ArticleIdList": ["10.1155/2011/586506", "PMC2957173", "20976081"]}, {"Citation": "Arun L.B., Arunachalam A.M., Arunachalam K.D., Annamalai S.K., Kumar K.A. In vivo anti-ulcer, anti-stress, anti-allergic, and functional properties of Gymnemic acid isolated from Gymnema sylvestre R Br. BMC Compl. Alternative. Med. 2014;14:70. doi: 10.1186/1472-6882-14-70.", "ArticleIdList": ["10.1186/1472-6882-14-70", "PMC3936851", "24559073"]}, {"Citation": "Balachandar V., Mahalaxmi I., Kaavya J., Vivek G., Ajithkumar S., Arul N., Singaravelu G., Nachimuthu S.K., Mohana Devi S. COVID-19: emerging protective measures. Eur. Rev. Med. Pharmaco. 2020;24 (In Press)", "ArticleIdList": ["32271461"]}, {"Citation": "Baranov P.V., Henderson C.M., Anderson C.B., Gesteland R.F., Atkins J.F., Howard M.T. Programmed ribosomal frameshifting in decoding the SARS-CoV genome. Virology. 2005;332:498\u2013510. doi: 10.1016/j.virol.2004.11.038.", "ArticleIdList": ["10.1016/j.virol.2004.11.038", "PMC7111862", "15680415"]}, {"Citation": "Beaucourt S., Vignuzzi M. Ribavirin: a drug active against many viruses with multiple effects on virus replication and propagation. Molecular basis of ribavirin resistance. Curr. Opin. Virol. 2014;8:10\u201315. doi: 10.1016/j.coviro.2014.04.011.", "ArticleIdList": ["10.1016/j.coviro.2014.04.011", "PMC7102760", "24846716"]}, {"Citation": "Beck B.R., Shin B., Choi Y., Park S., Kang K. Predicting commercially availableantiviral drugs that may act on the novel coronavirus (2019-nCoV), Wuhan, China through a drug-target interaction deep learning model. bioRxiv. 2020 doi: 10.1101/2020.01.31.929547.", "ArticleIdList": ["10.1101/2020.01.31.929547", "PMC7118541", "32280433"]}, {"Citation": "Bertram S., Dijkman R., Habjan M., Heurich A., Gierer S., Glowacka I., Welsch K., Winkler M., Schneider H., Hofmann-Winkler H. TMPRSS2 activates the human coronavirus 229E for cathepsin-independent host cell entry and is expressed in viral target cells in the respiratory epithelium. J. Virol. 2013;87:6150\u20136160. doi: 10.1128/JVI.03372-12.", "ArticleIdList": ["10.1128/JVI.03372-12", "PMC3648130", "23536651"]}, {"Citation": "Blanchard J.E., Elowe N.H., Huitema C., Fortin P.D., Cechetto J.D., Eltis L.D., Brown E.D. High-throughput screening identifies inhibitors of the SARS coronavirus main proteinase. Chem. Biol. 2004;11:1445\u20131453. doi: 10.1016/j.chembiol.2004.08.011.", "ArticleIdList": ["10.1016/j.chembiol.2004.08.011", "PMC7134594", "15489171"]}, {"Citation": "Brian D., Baric R. Coronavirus genome structure and replication. Curr. Top. Microbiol. Immunol. 2005;287:1\u201330. doi: 10.1007/3-540-26765-4_1.", "ArticleIdList": ["10.1007/3-540-26765-4_1", "PMC7120446", "15609507"]}, {"Citation": "Bunte K., Beikler T. Th17 cells and the IL-23/IL-17 axis in the pathogenesis of periodontitis and immune-mediated inflammatory diseases. Int. J. Mol. Sci. 2019;20:3394. doi: 10.3390/ijms20143394.", "ArticleIdList": ["10.3390/ijms20143394", "PMC6679067", "31295952"]}, {"Citation": "Cao Y. 2020. Suggestion Using Alcohol Vaporization or Nebulization Inhalation Therapy for Pneumonitis Caused by Coronavirus. (Available at SSRN 3545744)"}, {"Citation": "Cecere T.E., Todd S.M., LeRoith T. Regulatory T cells in arterivirus and coronavirus infections: do they protect against disease or enhance it? Viruses. 2012;4:833\u2013846. doi: 10.3390/v4050833.", "ArticleIdList": ["10.3390/v4050833", "PMC3386620", "22754651"]}, {"Citation": "Centers for Disease Prevention and Control (CDC) 2020. https://www.cdc.gov/coronavirus/2019-ncov/index.html (Accessed on 25 March 2020)"}, {"Citation": "Chan J.F.W., Kok K.H., Zhu Z., Chu H., To K.K.W., Yuan S., Yuen K.Y. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg. Microbes Infect. 2020;9:221\u2013236.", "ArticleIdList": ["PMC7067204", "31987001"]}, {"Citation": "Chan J.F.W., Yip C.C.Y., To K.K.W., Tang T.H.C., Wong S.C.Y., Leung K.H., Fung A.Y.F., Ng A.C.K., Zou Z., Tsoi H.W. Improved molecular diagnosis of COVID-19 by the novel, highly sensitive and specific COVID-19-RdRp/Hel real-time reverse transcription-polymerase chain reaction assay validated in vitro and with clinical specimens. J. Clin. Microbiol. 2020 doi: 10.1128/JCM.00310-20.", "ArticleIdList": ["10.1128/JCM.00310-20", "PMC7180250", "32132196"]}, {"Citation": "Cheema S.U.R., Rehman M.S., Hussain G., Cheema S.S., Gilani N. Efficacy and tolerability of sofosbuvir and daclatasvir for treatment of hepatitis C genotype 1 & 3 in patients undergoing hemodialysis-a prospective interventional clinical trial. BMC Nephrol. 2019;20:438. doi: 10.1186/s12882-019-1631-4.", "ArticleIdList": ["10.1186/s12882-019-1631-4", "PMC6883698", "31779583"]}, {"Citation": "Chen J. Pathogenicity and transmissibility of 2019-nCoV\u2014a quick overview and comparison with other emerging viruses. Microbes Infect. 2020;22:69\u201371. doi: 10.1016/j.micinf.2020.01.004.", "ArticleIdList": ["10.1016/j.micinf.2020.01.004", "PMC7102641", "32032682"]}, {"Citation": "Chen J., Lau Y.F., Lamirande E.W., Paddock C.D., Bartlett J.H., Zaki S.R., Subbarao K. Cellular immune responses to severe acute respiratory syndrome coronavirus (SARS-CoV) infection in senescent BALB/c mice: CD4+ T cells are important in control of SARS-CoV infection. J. Virol. 2010;84:1289\u20131301. doi: 10.1128/JVI.01281-09.", "ArticleIdList": ["10.1128/JVI.01281-09", "PMC2812346", "19906920"]}, {"Citation": "Chen H., Guo J., Wang C., Luo F., Yu X., Zhang W., Li J., Zhao D., Xu D., Gong Q. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet. 2020;395:809\u2013815. doi: 10.1016/S0140-6736(20)30360-3.", "ArticleIdList": ["10.1016/S0140-6736(20)30360-3", "PMC7159281", "32151335"]}, {"Citation": "Chou C.Y., Chien C.H., Han Y.S., Prebanda M.T., Hsieh H.P., Turk B., Chang G.G., Chen X. Thiopurine analogues inhibit papain-like protease of severe acute respiratory syndrome coronavirus. Biochem. Pharmacol. 2008;75:1601\u20131609. doi: 10.1016/j.bcp.2008.01.005.", "ArticleIdList": ["10.1016/j.bcp.2008.01.005", "PMC7092826", "18313035"]}, {"Citation": "Chu C., Cheng V., Hung I., Wong M., Chan K.H., Chan K.S., Kao R., Poon L., Wong C., Guan Y. Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings. Thorax. 2004;59:252\u2013256. doi: 10.1136/thorax.2003.012658.", "ArticleIdList": ["10.1136/thorax.2003.012658", "PMC1746980", "14985565"]}, {"Citation": "Cinatl J., Morgenstern B., Bauer G., Chandra P., Rabenau H., Doerr H. Treatment of SARS with human interferons. Lancet. 2003;362:293\u2013294. doi: 10.1016/s0140-6736(03)13973-6.", "ArticleIdList": ["10.1016/s0140-6736(03)13973-6", "PMC7112413", "12892961"]}, {"Citation": "Comper W. Charged polysaccharides resistant to lysosomal degradation during kidney filtration and renal passage and their use to treat or prevent infection by coronaviruses. 2005. https://europepmc.org/article/pat/wo2004093888"}, {"Citation": "Contini A. Virtual screening of an FDA approved drugs database on two COVID-19 coronavirus proteins. Chem Rxiv. 2020 doi: 10.26434/chemrxiv.11847381.v1.", "ArticleIdList": ["10.26434/chemrxiv.11847381.v1"]}, {"Citation": "Coon J.T., Ernst E. Andrographis paniculata in the treatment of upper respiratorytract infections: a systematic review of safety and efficacy. Planta Med. 2004;70:293\u2013298. doi: 10.1055/s-2004-818938.", "ArticleIdList": ["10.1055/s-2004-818938", "15095142"]}, {"Citation": "Cordes A.K., Heim A. Rapid random-access detection of the novel SARS-coronavirus-2 (SARS-CoV-2, previously 2019-nCoV) using an open access protocol for the panther fusion. J. Clin. Virol. 2020;125:104305. doi: 10.1016/j.jcv.2020.104305.", "ArticleIdList": ["10.1016/j.jcv.2020.104305", "PMC7129486", "32143123"]}, {"Citation": "Coutard B., Valle C., de Lamballerie X., Canard B., Seidah N., Decroly E. The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade. Antivir. Res. 2020;176:104742. doi: 10.1016/j.antiviral.2020.104742.", "ArticleIdList": ["10.1016/j.antiviral.2020.104742", "PMC7114094", "32057769"]}, {"Citation": "Cragg G.M., Newman D.J., Snader K.M. Natural products in drug discovery and development. J. Nat. Prod. 1997;60:52\u201360. doi: 10.1021/np9604893.", "ArticleIdList": ["10.1021/np9604893", "9014353"]}, {"Citation": "De Clercq E. Three decades of antiviral drugs. Nat. Rev. Drug Discov. 2007;6:941. doi: 10.1038/nrd2485.", "ArticleIdList": ["10.1038/nrd2485"]}, {"Citation": "De Clercq E. Anti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV. Int. J. Antimicrob. Agents. 2009;33:307\u2013320. doi: 10.1016/j.ijantimicag.2008.10.010.", "ArticleIdList": ["10.1016/j.ijantimicag.2008.10.010", "19108994"]}, {"Citation": "De Haan C.A., Rottier P.J. Molecular interactions in the assembly of coronaviruses. Adv. Virus Res. 2005;64:165\u2013230. doi: 10.1016/S0065-3527(05)64006-7.", "ArticleIdList": ["10.1016/S0065-3527(05)64006-7", "PMC7112327", "16139595"]}, {"Citation": "Diao B., Wang C., Tan Y., Chen X., Ying Liu, Ning L., Chen L., Li M., Yueping Liu, Wang G. 2020. Reduction and Functional Exhaustion of T Cells in Patients with Coronavirus Disease 2019 (COVID-19). medRxiv.", "ArticleIdList": ["10.1101/2020.02.18.20024364", "PMC7205903", "32425950"]}, {"Citation": "Dorigatti I., Okell L., Cori A., Imai N., Baguelin M., Bhatia S., Boonyasiri A., Cucunub\u00e1 Z., Cuomo-Dannenburg G., FitzJohn R. Imperial College; 2020. Report 4: Severity of 2019-Novel Coronavirus (nCoV)", "ArticleIdList": ["10.25561/77154"]}, {"Citation": "Dub\u00e9 M., Le Coupanec A., Wong A.H., Rini J.M., Desforges M., Talbot P.J. Axonal transport enables neuron-to-neuron propagation of human coronavirus OC43. J.Virol. 2018;92:404\u2013418. doi: 10.1128/JVI.00404-18.", "ArticleIdList": ["10.1128/JVI.00404-18", "PMC6096804", "29925652"]}, {"Citation": "Edwin G.T., Korsik M., Todd M.H. The past, present and future of anti-malarial medicines. Mala. J. 2019;18:93. doi: 10.1186/s12936-019-2724-z.", "ArticleIdList": ["10.1186/s12936-019-2724-z", "PMC6431062", "30902052"]}, {"Citation": "Elfiky A.A. Anti-HCV, nucleotide inhibitors, repurposing against COVID-19. Life Sci. 2020;248:117477. doi: 10.1016/j.lfs.2020.117477.", "ArticleIdList": ["10.1016/j.lfs.2020.117477", "PMC7089605", "32119961"]}, {"Citation": "Fabricant D.S., Farnsworth N.R. The value of plants used in traditional medicine for drug discovery. Environ. Health Perspect. 2001;109:69\u201375. doi: 10.1289/ehp.01109s169.", "ArticleIdList": ["10.1289/ehp.01109s169", "PMC1240543", "11250806"]}, {"Citation": "Fehr A.R., Perlman S. Coronaviruses: an overview of their replication and pathogenesis. Methods Mol. Biol. 2015;1282:1\u201323.", "ArticleIdList": ["PMC4369385", "25720466"]}, {"Citation": "Fiore C., Eisenhut M., Krausse R., Ragazzi E., Pellati D., Armanini D., Bielenberg J. Antiviral effects of Glycyrrhiza species. Phytother. Res. 2008;22:141\u2013148. doi: 10.1002/ptr.2295.", "ArticleIdList": ["10.1002/ptr.2295", "PMC7167979", "17886224"]}, {"Citation": "Galani V.J., Patel B.G., Rana D.G. Sphaeranthus indicus Linn.: a phytopharmacological review. Int. J. Ayurveda. Res. 2010;1:247\u2013253. doi: 10.4103/0974-7788.76790.", "ArticleIdList": ["10.4103/0974-7788.76790", "PMC3059449", "21455454"]}, {"Citation": "Ganjhu R.K., Mudgal P.P., Maity H., Dowarha D., Devadiga S., Nag S., Arunkumar G. Herbal plants and plant preparations as remedial approach for viral diseases. Virusdisease. 2015;26:225\u2013236. doi: 10.1007/s13337-015-0276-6.", "ArticleIdList": ["10.1007/s13337-015-0276-6", "PMC4663710", "26645032"]}, {"Citation": "Gierer S., Bertram S., Kaup F., Wrensch F., Heurich A., Kr\u00e4mer-K\u00fchl A., Welsch K., Winkler M., Meyer B., Drosten C. The spike protein of the emerging betacoronavirus EMC uses a novel coronavirus receptor for entry, can be activated by TMPRSS2, and is targeted by neutralizing antibodies. J. Virol. 2013;87:5502\u20135511. doi: 10.1128/JVI.00128-13.", "ArticleIdList": ["10.1128/JVI.00128-13", "PMC3648152", "23468491"]}, {"Citation": "Gilani A.H., Khan A., Raoof M., Ghayur M.N., Siddiqui B.S., Vohra W., Begum S. Gastrointestinal, selective airways and urinary bladder relaxant effects of Hyoscyamus niger are mediated through dual blockade of muscarinic receptors and Ca2+ channels. Fundam. Clin. Pharmacol. 2008;22:87\u201399. doi: 10.1111/j.1472-8206.2007.00561.x.", "ArticleIdList": ["10.1111/j.1472-8206.2007.00561.x", "18251725"]}, {"Citation": "Glass W.G., Subbarao K., Murphy B., Murphy P.M. Mechanisms of host defense following severe acute respiratory syndrome-coronavirus (SARS-CoV) pulmonary infection of mice. J. Immunol. 2004;173:4030\u20134039. doi: 10.4049/jimmunol.173.6.4030.", "ArticleIdList": ["10.4049/jimmunol.173.6.4030", "15356152"]}, {"Citation": "Gomathi M., Padmapriya S., Balachandar V. Drug studies on Rett syndrome: from bench to bedside. J. Autism Dev. Disord. 2020:1\u201325. doi: 10.1007/s10803-020-04381-y.", "ArticleIdList": ["10.1007/s10803-020-04381-y", "32016693"]}, {"Citation": "Gorbalenya A.E. Severe acute respiratory syndrome-related coronavirus\u2013the species and its viruses, a statement of the coronavirus study group. BioRxiv. 2020 doi: 10.1101/2020.02.07.937862.", "ArticleIdList": ["10.1101/2020.02.07.937862"]}, {"Citation": "Gorbalenya A.E., Baker S.C., Baric R.S., de Groot R.J., Drosten C., Gulyaeva A.A., Haagmans B.L., Lauber C., Leontovich A.M., Neuman B.W., Penzar D., Perlman S., Poon L.L.M., Samborskiy D.V., Sidorov I.A., Sola I., Ziebuhr J. The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat. Microbiol. 2020;5:536\u2013544. doi: 10.1038/s41564-020-0695-z.", "ArticleIdList": ["10.1038/s41564-020-0695-z", "PMC7095448", "32123347"]}, {"Citation": "Guarner J. Three emerging coronaviruses in two decades the story of SARS, MERS, and now COVID-19. Am. J. Clin. Path. 2020;153:420\u2013421. doi: 10.1093/ajcp/aqaa029.", "ArticleIdList": ["10.1093/ajcp/aqaa029", "PMC7109697", "32053148"]}, {"Citation": "Guerrero E., Vasudevaraju P., Hegde M.L., Britton G., Rao K. Recent advances in \u03b1-synuclein functions, advanced glycation, and toxicity: implications for Parkinson\u2019s disease. Mol. Neurobiol. 2013;47:525\u2013536. doi: 10.1007/s12035-012-8328-z.", "ArticleIdList": ["10.1007/s12035-012-8328-z", "22923367"]}, {"Citation": "Gurib-Fakim A. Medicinal plants: traditions of yesterday and drugs of tomorrow. Mol. Asp. Med. 2006;27:1\u201393. doi: 10.1016/j.mam.2005.07.008.", "ArticleIdList": ["10.1016/j.mam.2005.07.008", "16105678"]}, {"Citation": "Haagmans B.L., Kuiken T., Martina B.E., Fouchier R.A., Rimmelzwaan G.F., Van Amerongen G., van Riel D., De Jong T., Itamura S., Chan K.-H. Pegylated interferon-\u03b1 protects type 1 pneumocytes against SARS coronavirus infection in macaques. Nat. Med. 2004;10:290\u2013293. doi: 10.1038/nm1001.", "ArticleIdList": ["10.1038/nm1001", "PMC7095986", "14981511"]}, {"Citation": "Habibzadeh P., Stoneman E.K. The novel coronavirus: a bird\u2019s eye view. Int. J. Occup. Environ. Med. 2020;11:65. doi: 10.15171/ijoem.2020.1921.", "ArticleIdList": ["10.15171/ijoem.2020.1921", "PMC7205509", "32020915"]}, {"Citation": "Harcourt B.H., Jukneliene D., Kanjanahaluethai A., Bechill J., Severson K.M., Smith C.M., Rota P.A., Baker S.C. Identification of severe acute respiratory syndrome coronavirus replicase products and characterization of papain-like protease activity. J. Virol. 2004;78:13600\u201313612. doi: 10.1128/JVI.78.24.13600-13612.2004.", "ArticleIdList": ["10.1128/JVI.78.24.13600-13612.2004", "PMC533933", "15564471"]}, {"Citation": "He L., Qi Y., Rong X., Jiang J., Yang Q., Yamahara J., Murray M., Li Y. The Ayurvedic medicine Salacia oblonga attenuates diabetic renal fibrosis in rats: suppression of angiotensin II/AT1 signaling. Evid. Based Complement. Alternat. Med. 2011;2011:12. doi: 10.1093/ecam/nep095.", "ArticleIdList": ["10.1093/ecam/nep095", "PMC3137643", "19706694"]}, {"Citation": "Heymann D.L., Shindo N. COVID-19: what is next for public health? Lancet. 2020;395:542\u2013545. doi: 10.1016/S0140-6736(20)30374-3.", "ArticleIdList": ["10.1016/S0140-6736(20)30374-3", "PMC7138015", "32061313"]}, {"Citation": "Hoffmann M., Kleine-Weber H., Krueger N., Mueller M.A., Drosten C., P\u00f6hlmann S. The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells. BioRxiv. 2020 doi: 10.1101/2020.01.31.929042.", "ArticleIdList": ["10.1101/2020.01.31.929042"]}, {"Citation": "Howard M.W., Travanty E.A., Jeffers S.A., Smith M., Wennier S.T., Thackray L.B., Holmes K.V. Aromatic amino acids in the juxtamembrane domain of severe acute respiratory syndrome coronavirus spike glycoprotein are important for receptor-dependent virus entry and cell-cell fusion. J. Virol. 2008;82:2883\u20132894. doi: 10.1128/JVI.01805-07.", "ArticleIdList": ["10.1128/JVI.01805-07", "PMC2258972", "18199653"]}, {"Citation": "Hsieh L.E., Lin C.N., Su B.L., Jan T.R., Chen C.M., Wang C.H., Lin D.S., Lin C.T., Chueh L.L. Synergistic antiviral effect of Galanthus nivalis agglutinin and nelfinavir against feline coronavirus. Antivir. Res. 2010;88:25\u201330. doi: 10.1016/j.antiviral.2010.06.010.", "ArticleIdList": ["10.1016/j.antiviral.2010.06.010", "PMC7114315", "20603153"]}, {"Citation": "Hu F., Jiang J., Yin P. 2020. Prediction of Potential Commercially Inhibitors Against SARS-CoV-2 by Multi-task Deep Model. arXiv:2003.00728.", "ArticleIdList": ["PMC9405964", "36009050"]}, {"Citation": "Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497\u2013506. doi: 10.1016/S0140-6736(20)30183-5.", "ArticleIdList": ["10.1016/S0140-6736(20)30183-5", "PMC7159299", "31986264"]}, {"Citation": "Hussain F., Jahan N., Rahman K., Sultana B., Jamil S. Identification of hypotensive biofunctional compounds of Coriandrum sativum and evaluation of their angiotensin-converting enzyme (ACE) inhibition potential. Oxidative Med. Cell. Longev. 2018;3:1\u201311. doi: 10.1155/2018/4643736.", "ArticleIdList": ["10.1155/2018/4643736", "PMC6276458", "30581531"]}, {"Citation": "Imbert I., Guillemot J., Bourhis J., Bussetta C., Coutard B., Egloff M., Ferron F., Gorbalenya A.E., Canard B. A second, non-canonical RNA-dependent RNA polymerase in SARS coronavirus. EMBO J. 2006;25:4933\u20134942. doi: 10.1038/sj.emboj.7601368.", "ArticleIdList": ["10.1038/sj.emboj.7601368", "PMC1618104", "17024178"]}, {"Citation": "Indian Council of Medical Research (ICMR) 2020. https://icmr.nic.in/sites/default/files/whats_new/ICMR_website_update_25Mrarch_8PM_IST.pdf"}, {"Citation": "Janice Oh H.L., Ken-En Gan S., Bertoletti A., Tan Y.J. Understanding the T cell immune response in SARS coronavirus infection. Emerg. Microbes. Infect. 2012;1:1\u20136. doi: 10.1038/emi.2012.26.", "ArticleIdList": ["10.1038/emi.2012.26", "PMC3636424", "26038429"]}, {"Citation": "Jiang X., Kanda T., Nakamoto S., Saito K., Nakamura M., Wu S., Haga Y., Sasaki R., Sakamoto N., Shirasawa H. The JAK2 inhibitor AZD1480 inhibits hepatitis A virus replication in Huh7 cells. Biochem. Biophys. Res. Commun. 2015;458:908\u2013912. doi: 10.1016/j.bbrc.2015.02.058.", "ArticleIdList": ["10.1016/j.bbrc.2015.02.058", "25704089"]}, {"Citation": "Jiang S., Shi Z., Shu Y., Song J., Gao G.F., Tan W., Guo D. A distinct name is needed for the new coronavirus. Lancet. 2020;395:949. doi: 10.1016/S0140-6736(20)30419-0.", "ArticleIdList": ["10.1016/S0140-6736(20)30419-0", "PMC7124603", "32087125"]}, {"Citation": "Jin Y.H., Cai L., Cheng Z.S., Cheng H., Deng T., Fan Y.P., Fang C., Huang D., Huang L.Q., Huang Q. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version) Military. Med. Res. 2020;7:4. doi: 10.1186/s40779-020-0233-6.", "ArticleIdList": ["10.1186/s40779-020-0233-6", "PMC7003341", "32029004"]}, {"Citation": "Kannan S., Ali P.S.S., Sheeza A., Hemalatha K. COVID-19 (Novel Coronavirus 2019)\u2013recent trends. Eur. Rev. Med. Pharmacol. Sci. 2020;24:2006\u20132011. doi: 10.26355/eurrev_202002_20378.", "ArticleIdList": ["10.26355/eurrev_202002_20378", "32141569"]}, {"Citation": "Karakus U., Pohl M.O., Stertz S. Breaking the convention: sialoglycan variants, coreceptors, and alternative receptors for influenza a virus entry. J. Virol. 2020;94 doi: 10.1128/JVI.01357-19.", "ArticleIdList": ["10.1128/JVI.01357-19", "PMC6997770", "31776280"]}, {"Citation": "Kawase M., Shirato K., van der Hoek L., Taguchi F., Matsuyama S. Simultaneous treatment of human bronchial epithelial cells with serine and cysteine protease inhibitors prevents severe acute respiratory syndrome coronavirus entry. J. Virol. 2012;86:6537\u20136545. doi: 10.1128/JVI.00094-12.", "ArticleIdList": ["10.1128/JVI.00094-12", "PMC3393535", "22496216"]}, {"Citation": "Keyaerts E., Vijgen L., Maes P., Neyts J., Van Ranst M. In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine. Biochem. Biophys. Res. Commun. 2004;323:264\u2013268. doi: 10.1016/j.bbrc.2004.08.085.", "ArticleIdList": ["10.1016/j.bbrc.2004.08.085", "PMC7092815", "15351731"]}, {"Citation": "Keyaerts E., Vijgen L., Pannecouque C., Van Damme E., Peumans W., Egberink H., Balzarini J., Van Ranst M. Plant lectins are potent inhibitors of coronaviruses by interfering with two targets in the viral replication cycle. Antivir. Res. 2007;75:179\u2013187. doi: 10.1016/j.antiviral.2007.03.003.", "ArticleIdList": ["10.1016/j.antiviral.2007.03.003", "PMC7114093", "17428553"]}, {"Citation": "Keyaerts E., Li S., Vijgen L., Rysman E., Verbeeck J., Van Ranst M., Maes P. Antiviral activity of chloroquine against human coronavirus OC43 infection in newborn mice. Antimicrob. Agents Chemother. 2009;53:3416\u20133421. doi: 10.1128/AAC.01509-08.", "ArticleIdList": ["10.1128/AAC.01509-08", "PMC2715625", "19506054"]}, {"Citation": "Khan M.Y., Kumar V. Mechanism & inhibition kinetics of bioassay-guided fractions of Indian medicinal plants and foods as ACE inhibitors. J. Tradit. Complement. Med. 2019;9:73\u201384. doi: 10.1016/j.jtcme.2018.02.001.", "ArticleIdList": ["10.1016/j.jtcme.2018.02.001", "PMC6335474", "30671369"]}, {"Citation": "Kilianski A., Mielech A.M., Deng X., Baker S.C. Assessing activity and inhibition of Middle East respiratory syndrome coronavirus papain-like and 3C-like proteases using luciferase-based biosensors. J. Virol. 2013;87:11955\u201311962. doi: 10.1128/JVI.02105-13.", "ArticleIdList": ["10.1128/JVI.02105-13", "PMC3807373", "23986593"]}, {"Citation": "Killerby M.E., Biggs H.M., Haynes A., Dahl R.M., Mustaquim D., Gerber S.I., Watson J.T. Human coronavirus circulation in the United States 2014\u20132017. J. Clin. Virol. 2018;101:52\u201356. doi: 10.1016/j.jcv.2018.01.019.", "ArticleIdList": ["10.1016/j.jcv.2018.01.019", "PMC7106380", "29427907"]}, {"Citation": "Kim I., Lee J.E., Kim K.H., Lee S., Lee K., Mok J.H. Successful treatment of suspected organizing pneumonia in a patient with Middle East respiratory syndrome coronavirus infection: a case report. J. Thorac. Dis. 2016;8(10):E1190.", "ArticleIdList": ["PMC5107491", "27867585"]}, {"Citation": "Konrad R., Eberle U., Dangel A., Treis B., Berger A., Bengs K., Fingerle V., Liebl B., Ackermann N., Sing A. Rapid establishment of laboratory diagnostics for the novel coronavirus SARS-CoV-2 in Bavaria, Germany, February 2020. Euro. Surveill. 2020;25:2000173. doi: 10.2807/1560-7917.ES.2020.25.9.2000173.", "ArticleIdList": ["10.2807/1560-7917.ES.2020.25.9.2000173", "PMC7068163", "32156330"]}, {"Citation": "Kruse R.L. Therapeutic strategies in an outbreak scenario to treat the novel coronavirus originating in Wuhan, China. F1000Res. 2020;9:72. doi: 10.12688/f1000research.22211.2.", "ArticleIdList": ["10.12688/f1000research.22211.2", "PMC7029759", "32117569"]}, {"Citation": "Lei P., Fan B., Mao J., Wang P. Comprehensive analysis for diagnosis of novel coronavirus disease (COVID-19) infection. J. Inf. Secur. 2020 doi: 10.1016/j.jinf.2020.03.016.", "ArticleIdList": ["10.1016/j.jinf.2020.03.016", "0"]}, {"Citation": "Lewinsohn D.M., Bowden R.A., Mattson D., Crawford S.W. Phase I study of intravenous ribavirin treatment of respiratory syncytial virus pneumonia after marrow transplantation. Antimicrob. Agents Chemother. 1996;40:2555\u20132557.", "ArticleIdList": ["PMC163574", "8913463"]}, {"Citation": "Leyva-Grado V.H., Behzadi M.A. Overview of current therapeutics and novel candidates against influenza, respiratory syncytial virus and Middle East respiratory syndrome coronavirus infections. Fronti. Microbiol. 2019;10:1327. doi: 10.3389/fmicb.2019.01327.", "ArticleIdList": ["10.3389/fmicb.2019.01327", "PMC6594388", "31275265"]}, {"Citation": "Li G., Clercq E. Therapeutic options for the 2019 novel coronavirus (2019-nCoV) Nat. Rev. Drug Discov. 2020;19:1449\u201314150. doi: 10.1038/d41573-020-00016-0.", "ArticleIdList": ["10.1038/d41573-020-00016-0", "32127666"]}, {"Citation": "Li Z., He W., Lan Y., Zhao K., Lv X., Lu H., Ding N., Zhang J., Shi J., Shan C. The evidence of porcine hemagglutinating encephalomyelitis virus induced nonsuppurative encephalitis as the cause of death in piglets. Peer. J. 2016;4:2443. doi: 10.7717/peerj.2443.", "ArticleIdList": ["10.7717/peerj.2443", "PMC5028786", "27672502"]}, {"Citation": "Li Y., Bai W., Hashikawa T. The neuroinvasive potential of SARS-CoV2 may be at least partially responsible for the respiratory failure of COVID-19 patients. J. Med. Virol. 2020 doi: 10.1002/jmv.25728.", "ArticleIdList": ["10.1002/jmv.25728", "PMC7228394", "32104915"]}, {"Citation": "Lin S., Shen R., He J., Li X., Guo X. 2020. Molecular Modeling Evaluation of the Binding Effect of Ritonavir, Lopinavir and Darunavir to Severe Acute Respiratory Syndrome Coronavirus 2 Proteases. BioRxiv.", "ArticleIdList": ["10.1101/2020.01.31.929695"]}, {"Citation": "Liou C.J., Cheng C.Y., Yeh K.W., Wu Y.H., Huang W.C. Protective effects of casticin from vitex trifolia alleviate eosinophilic airway inflammation and oxidative stress in a murine asthma model. Front. Pharma col. 2018;9:635. doi: 10.3389/fphar.2018.00635.", "ArticleIdList": ["10.3389/fphar.2018.00635", "PMC6010522", "29962952"]}, {"Citation": "Lippi G., Simundic A.M., Plebani M. Potential preanalytical and analytical vulnerabilities in the laboratory diagnosis of coronavirus disease 2019 (COVID-19) Clin. Chem. Lab. Med. 2020 doi: 10.1515/cclm-2020-0285.", "ArticleIdList": ["10.1515/cclm-2020-0285", "32172228"]}, {"Citation": "Liu D.X., Fung T.S., Chong K.K.-L., Shukla A., Hilgenfeld R. Accessory proteins of SARS-CoV and other coronaviruses. Antivir. Res. 2014;109:97\u2013109. doi: 10.1016/j.antiviral.2014.06.013.", "ArticleIdList": ["10.1016/j.antiviral.2014.06.013", "PMC7113789", "24995382"]}, {"Citation": "Liu Y.T., Chen H.W., Lii C.K., Jhuang J.H., Huang C.S., Li M.L., Yao H.T. A diterpenoid, 14-deoxy-11, 12-didehydroandrographolide, in Andrographis paniculata reduces steatohepatitis and liver injury in mice fed a high-fat and high-cholesterol diet. Nutrients. 2020;12:523. doi: 10.3390/nu12020523.", "ArticleIdList": ["10.3390/nu12020523", "PMC7071475", "32085637"]}, {"Citation": "Liu Z., Xiao X., Wei X., Li J., Yang J., Tan H., Zhu J., Zhang Q., Wu J., Liu L. Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2. J. Med. Virol. 2020 doi: 10.1002/jmv.25726.", "ArticleIdList": ["10.1002/jmv.25726", "PMC7228221", "32100877"]}, {"Citation": "Li-Weber M. New therapeutic aspects of flavones: the anticancer properties of Scutellaria and its main active constituents Wogonin, Baicalein and Baicalin. Cancer Treat. Rev. 2009;35:57\u201368. doi: 10.1016/j.ctrv.2008.09.005.", "ArticleIdList": ["10.1016/j.ctrv.2008.09.005", "19004559"]}, {"Citation": "Loeffelholz M.J., Tang Y.W. Laboratory diagnosis of emerging human coronavirus infections- the state of the art. Emerg. Microbes. Infect. 2020:1\u201326. doi: 10.1080/22221751.2020.1745095.", "ArticleIdList": ["10.1080/22221751.2020.1745095", "PMC7172701", "32196430"]}, {"Citation": "Lu H. Drug treatment options for the 2019-new coronavirus (2019-nCoV) Biosci. Trends. 2020 doi: 10.5582/bst.2020.01020.", "ArticleIdList": ["10.5582/bst.2020.01020", "31996494"]}, {"Citation": "Lu R., Zhao X., Li J., Niu P., Yang B., Wu H., Wang W., Song H., Huang B., Zhu N. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395:565\u2013574. doi: 10.1016/S0140-6736(20)30251-8.", "ArticleIdList": ["10.1016/S0140-6736(20)30251-8", "PMC7159086", "32007145"]}, {"Citation": "Mahy B.W., Siddell S., Wege H., Ter Meulen V. RNA-dependent RNA polymerase activity in murine coronavirus-infected cells. J. Gen. Virol. 1983;64:103\u2013111.", "ArticleIdList": ["6296295"]}, {"Citation": "Maity N., Nema N.K., Sarkar B.K., Mukherjee P.K. Standardized Clitoria ternatea leaf extract as hyaluronidase, elastase and matrix-metalloproteinase-1 inhibitor. Indian. J. pharmacol. 2012;44:584. doi: 10.4103/0253-7613.100381.", "ArticleIdList": ["10.4103/0253-7613.100381", "PMC3480789", "23112418"]}, {"Citation": "Maloir Q., Ghysen K., Louis R., Guiot J. Acute respiratory distress revealing antisynthetase syndrome. Rev. Med. Liege. 2018;73:370\u2013375.", "ArticleIdList": ["30113776"]}, {"Citation": "Manni M.L., Robinson K.M., Alcorn J.F. A tale of two cytokines: IL-17 and IL-22 in asthma and infection. Expert. Rev. Respir. Med. 2014;8:25\u201342. doi: 10.1586/17476348.2014.854167.", "ArticleIdList": ["10.1586/17476348.2014.854167", "PMC4123209", "24325586"]}, {"Citation": "March K., Bogatcheva N. Use of asc and asc-cm to treat ards, sars, and mers. 2018. http://www.freepatentsonline.com/10143709.html"}, {"Citation": "March. K., Bogatcheva, N., 2019. Use of asc and asc-cm to treat ards, sars, and mers. United States patent application US 16/177,103. 2019 Apr 25."}, {"Citation": "Markland W., McQuaid T., Jain J., Kwong A. Broad-spectrum antiviral activity of the IMP dehydrogenase inhibitor VX-497: a comparison with ribavirin and demonstration of antiviral additivity with alpha interferon. Antimicrob. Agents Chemother. 2000;44:859\u2013866. doi: 10.1128/aac.44.4.859-866.2000.", "ArticleIdList": ["10.1128/aac.44.4.859-866.2000", "PMC89783", "10722482"]}, {"Citation": "Matsuda K., Park C., Sunden Y., Kimura T., Ochiai K., Kida H., Umemura T. The vagus nerve is one route of transneural invasion for intranasally inoculated influenza a virus in mice. Vet. Pathol. 2004;41:101\u2013107. doi: 10.1354/vp.41-2-101.", "ArticleIdList": ["10.1354/vp.41-2-101", "15017022"]}, {"Citation": "Matthew A. 2020. Lost Smell and Taste Hint COVID-19 Can Target the Nervous System. The Scientist. Published on 24th March, 2020."}, {"Citation": "McIntosh K., Kurachek S.C., Cairns L.M., Burns J.C., Goodspeed B. Treatment of respiratory viral infection in an immunodeficient infant with ribavirin aerosol. Am. J, Dis. Child. 1984;138:305\u2013308.", "ArticleIdList": ["6322573"]}, {"Citation": "Mengeling W., WL M., AD B., AE R. Characteristics of a coronavirus (strain 67N) of pigs. Am. J. Vet. Res. 1972;33:297\u2013308.", "ArticleIdList": ["4551084"]}, {"Citation": "Ministry of Ayush, Government of India Homeopathy for prevention of coronavirus infections. 2020. https://pib.gov.in/PressReleasePage.aspx?PRID=1600895"}, {"Citation": "Mishra S., Aeri V., Gaur P.K., Jachak S.M. Phytochemical, therapeutic, and ethnopharmacological overview for a traditionally important herb: Boerhaviadiffusa Linn. Biomed. Res. Int. 2014;2014:808302. doi: 10.1155/2014/808302.", "ArticleIdList": ["10.1155/2014/808302", "PMC4053255", "24949473"]}, {"Citation": "Moghadamtousi S.Z., Nikzad S., Kadir H.A., Abubakar S., Zandi K. Potential antiviral agents from marine fungi: an overview. Mar. Drugs. 2015;13:4520\u20134538. doi: 10.3390/md13074520.", "ArticleIdList": ["10.3390/md13074520", "PMC4515631", "26204947"]}, {"Citation": "Mulangu S., Dodd L.E., Davey R.T., Jr., Tshiani Mbaya O., Proschan M., Mukadi D., Lusakibanza Manzo M., Nzolo D., Tshomba Oloma A., Ibanda A. A randomized, controlled trial of Ebola virus disease therapeutics. N. Engl. J. Med. 2019;381:2293\u20132303. doi: 10.1056/NEJMoa1910993.", "ArticleIdList": ["10.1056/NEJMoa1910993", "PMC10680050", "31774950"]}, {"Citation": "Nair R. HIV-1 reverse transcriptase inhibition by Vitex negundo L. leaf extract and quantification of flavonoids in relation to anti-HIV activity. J. Cell. Mol. Biol. 2012;10:53\u201359."}, {"Citation": "Nieto-Torres J.L., Verdi\u00e1-B\u00e1guena C., Jimenez-Guarde\u00f1o J.M., Regla-Nava J.A., Casta\u00f1o-Rodriguez C., Fernandez-Delgado R., Torres J., Aguilella V.M., Enjuanes L. Severe acute respiratory syndrome coronavirus E protein transports calcium ions and activates the NLRP3 inflammasome. Virology. 2015;485:330\u2013339. doi: 10.1016/j.virol.2015.08.010.", "ArticleIdList": ["10.1016/j.virol.2015.08.010", "PMC4619128", "26331680"]}, {"Citation": "Nourazarian A. Effect of root extracts of medicinal herb Glycyrrhiza glabra on HSP90 gene expression and apoptosis in the HT-29 colon cancer cell line. Asian Pac. J. Cancer Prev. 2015;2011:1\u201316. doi: 10.7314/APJCP.2015.16.18.8563.", "ArticleIdList": ["10.7314/APJCP.2015.16.18.8563", "26745117"]}, {"Citation": "Olivieri F., Prasad V., Valbonesi P., Srivastava S., Ghosal-Chowdhury P., Barbieri L., Bolognesi A., Stirpe F. A systemic antiviral resistance-inducing protein isolated from Clerodendrum inerme Gaertn. Is a polynucleotide: adenosine glycosidase (ribosome-inactivating protein) FEBS Lett. 1996;396:132\u2013134.", "ArticleIdList": ["8914973"]}, {"Citation": "Otake T., Mori H., Morimoto M., Ueba N., Sutardjo S., Kusumoto I.T., Hattori M., Namba T. Screening of Indonesian plant extracts for anti-human immunodeficiency virus\u2014type 1 (HIV-1) activity. Phytother. Res. 1995;9:6\u201310."}, {"Citation": "Pan P.P., Zhang Q.T., Le F., Zheng Y.M., Jin F. Angiotensin-converting enzymes play a dominant role in fertility. Int. J. Mol. Sci. 2013;14(10):21071\u201321086. doi: 10.3390/ijms141021071.", "ArticleIdList": ["10.3390/ijms141021071", "PMC3821659", "24152441"]}, {"Citation": "Pandey A., Bigoniya P., Raj V., Patel K.K. Pharmacological screening of Coriandrum sativum Linn. for hepatoprotective activity. J. Pharm. Bioallied. Sci. 2011;3(3):435. doi: 10.4103/0975-7406.84462.", "ArticleIdList": ["10.4103/0975-7406.84462", "PMC3178952", "21966166"]}, {"Citation": "Parasuraman S., Thing G.S., Dhanaraj S.A. Polyherbal formulation: concept of ayurveda. Pharmacogn. Rev. 2014;8:73. doi: 10.4103/0973-7847.134229.", "ArticleIdList": ["10.4103/0973-7847.134229", "PMC4127824", "25125878"]}, {"Citation": "Peiris J., Guan Y., Yuen K. Severe acute respiratory syndrome. Nat. Med. 2004;10:S88\u2013S97. doi: 10.1038/nm1143.", "ArticleIdList": ["10.1038/nm1143", "PMC7096017", "15577937"]}, {"Citation": "Peters H.L., Jochmans D., de Wilde A.H., Posthuma C.C., Snijder E.J., Neyts J., Seley-Radtke K.L. Design, synthesis and evaluation of a series of acyclic fleximer nucleoside analogues with anti-coronavirus activity. Bioorg. Med. Chem. Lett. 2015;25:2923\u20132926. doi: 10.1016/j.bmcl.2015.05.039.", "ArticleIdList": ["10.1016/j.bmcl.2015.05.039", "PMC4466200", "26048809"]}, {"Citation": "Phan T. Novel coronavirus: from discovery to clinical diagnostics. Infect. Genet. Evo. 2020;79:104211. doi: 10.1016/j.meegid.2020.104211.", "ArticleIdList": ["10.1016/j.meegid.2020.104211", "PMC7129799", "32007627"]}, {"Citation": "Prathapan A., Vineetha V., Abhilash P., Raghu K. Boerhaaviadiffusa L. attenuates angiotensin II-induced hypertrophy in H9c2 cardiac myoblast cells via modulating oxidative stress and down-regulating NF-\u03ba\u03b2 and transforming growth factor \u03b21. Br. J. Nutr. 2013;110:1201\u20131210. doi: 10.1017/S0007114513000561.", "ArticleIdList": ["10.1017/S0007114513000561", "23591029"]}, {"Citation": "Pundarikakshudu K., Kanaki N.S. Analysis and regulation of traditional Indian medicines (TIM) J. AOAC Int. 2019;102:977\u2013978. doi: 10.5740/jaoacint.18-0376.", "ArticleIdList": ["10.5740/jaoacint.18-0376", "30558694"]}, {"Citation": "Que T., Wong V., Yuen K. Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study. Hong Kong Med J. 2003;9:399\u2013406.", "ArticleIdList": ["14660806"]}, {"Citation": "Ravishankar B., Shukla V. Indian systems of medicine: a brief profile. Afr. J. Trad. Complement. Altern. Med. 2007;4:319\u2013337. doi: 10.4314/ajtcam.v4i3.31226.", "ArticleIdList": ["10.4314/ajtcam.v4i3.31226", "PMC2816487", "20161896"]}, {"Citation": "Razonable R.R. Antiviral drugs for viruses other than human immunodeficiency virus. Mayo Clin. Proc. 2011;86:1009\u20131026. doi: 10.4065/mcp.2011.0309.", "ArticleIdList": ["10.4065/mcp.2011.0309", "PMC3184032", "21964179"]}, {"Citation": "Rege A., Chowdhary A.S. Evaluation of Ocimum sanctum and Tinospora cordifolia as probable HIV protease inhibitors. Int. J. of Pharm. Sci. Rev. Res. 2014;25:315\u2013318."}, {"Citation": "Richardson P., Griffin I., Tucker C., Smith D., Oechsle O., Phelan A., Stebbing J. Baricitinib as potential treatment for 2019-nCoV acute respiratory disease. Lancet. 2020;395:30\u201331. doi: 10.1016/S0140-6736(20)30304-4.", "ArticleIdList": ["10.1016/S0140-6736(20)30304-4", "PMC7137985", "32032529"]}, {"Citation": "Rossignol J.-F. Nitazoxanide, a new drug candidate for the treatment of Middle East respiratory syndrome coronavirus. J. Infect. Public. Health. 2016;9:227\u2013230. doi: 10.1016/j.jiph.2016.04.001.", "ArticleIdList": ["10.1016/j.jiph.2016.04.001", "PMC7102735", "27095301"]}, {"Citation": "Rudra S., Kalra A., Kumar A., Joe W. Utilization of alternative systems of medicine as health care services in India: evidence on AYUSH care from NSS 2014. PLoS One. 2017;12:e0176916. doi: 10.1371/journal.pone.0176916.", "ArticleIdList": ["10.1371/journal.pone.0176916", "PMC5417584", "28472197"]}, {"Citation": "Schoeman D., Fielding B.C. Coronavirus envelope protein: current knowledge. Virology. J. 2019;16:69. doi: 10.1186/s12985-019-1182-0.", "ArticleIdList": ["10.1186/s12985-019-1182-0", "PMC6537279", "31133031"]}, {"Citation": "Scior T., Bender A., Tresadern G., Medina-Franco J.L., Mart\u00ednez-Mayorga K., Langer T., Cuanalo-Contreras K., Agrafiotis D.K. Recognizing pitfalls in virtual screening: a critical review. J. Chem. Inf. Model. 2012;52:867\u2013881. doi: 10.1021/ci200528d.", "ArticleIdList": ["10.1021/ci200528d", "22435959"]}, {"Citation": "Shanti B.M. Perspective of potential plants for medicine from Rajasthan, India, Int. J. Pharm. Res. 2016;7(1):1\u20136."}, {"Citation": "Shi C.-S., Nabar N.R., Huang N.-N., Kehrl J.H. SARS-coronavirus open reading frame-8b triggers intracellular stress pathways and activates NLRP3 inflammasomes. Cell. Death. Discov. 2019;5:1\u201312. doi: 10.1038/s41420-019-0181-7.", "ArticleIdList": ["10.1038/s41420-019-0181-7", "PMC6549181", "31231549"]}, {"Citation": "Shi F., Yu Q., Huang W., Tan C. 2019 novel coronavirus (COVID-19) pneumonia with hemoptysis as the initial symptom: CT and clinical features. Korean J. Radiol. 2020 doi: 10.1148/radiol.2020200490.", "ArticleIdList": ["10.1148/radiol.2020200490", "PMC7183833", "32174057"]}, {"Citation": "Shirato K., Yano T., Senba S., Akachi S., Kobayashi T., Nishinaka T., Notomi T., Matsuyama S. Detection of Middle East respiratory syndrome coronavirus using reverse transcription loop-mediated isothermal amplification (RT-LAMP) Virol. J. 2014;11:139. doi: 10.1186/1743-422X-11-139.", "ArticleIdList": ["10.1186/1743-422X-11-139", "PMC4132226", "25103205"]}, {"Citation": "Simmons G., Gosalia D.N., Rennekamp A.J., Reeves J.D., Diamond S.L., Bates P. Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry. Proc. Natl. Acad. Sci. 2005;102(33):11876\u201311881.", "ArticleIdList": ["PMC1188015", "16081529"]}, {"Citation": "Simmons G., Zmora P., Gierer S., Heurich A., P\u00f6hlmann S. Proteolytic activation of the SARS-coronavirus spike protein: cutting enzymes at the cutting edge of antiviral research. Antivir. Res. 2013;100:605\u2013614. doi: 10.1016/j.antiviral.2013.09.028.", "ArticleIdList": ["10.1016/j.antiviral.2013.09.028", "PMC3889862", "24121034"]}, {"Citation": "Siu Y., Teoh K., Lo J., Chan C., Kien F., Escriou N., Tsao S., Nicholls J., Altmeyer R., Peiris J. The M, E, and N structural proteins of the severe acute respiratory syndrome coronavirus are required for efficient assembly, trafficking, and release of virus-like particles. J. Virol. 2008;82:11318\u201311330. doi: 10.1128/JVI.01052-08.", "ArticleIdList": ["10.1128/JVI.01052-08", "PMC2573274", "18753196"]}, {"Citation": "Siu K.L., Yuen K.S., Casta\u00f1o-Rodriguez C., Ye Z.W., Yeung M.L., Fung S.Y., Yuan S., Chan C.P., Yuen K.Y., Enjuanes L. Severe acute respiratory syndrome coronavirus ORF3a protein activates the NLRP3 inflammasome by promoting TRAF3-dependent ubiquitination of ASC. FASEB J. 2019;33:8865\u20138877. doi: 10.1096/fj.201802418R.", "ArticleIdList": ["10.1096/fj.201802418R", "PMC6662968", "31034780"]}, {"Citation": "Song Z., Xu Y., Bao L., Zhang L., Yu P., Qu Y., Zhu H., Zhao W., Han Y., Qin C. From SARS to MERS, thrusting coronaviruses into the spotlight. Viruses. 2019;11:59. doi: 10.3390/v11010059.", "ArticleIdList": ["10.3390/v11010059", "PMC6357155", "30646565"]}, {"Citation": "Srivastava R.A.K., Mistry S., Sharma S. A novel anti-inflammatory natural product from Sphaeranthus indicus inhibits expression of VCAM1 and ICAM1, and slows atherosclerosis progression independent of lipid changes. Nutr. Metab. 2015;12:20. doi: 10.1186/s12986-015-0018-1.", "ArticleIdList": ["10.1186/s12986-015-0018-1", "PMC4462118", "26064179"]}, {"Citation": "Stebbing J., Phelan A., Griffin I., Tucker C., Oechsle O., Smith D., Richardson P. COVID-19: combining antiviral and anti-inflammatory treatments. Lancet Infect. Dis. 2020 doi: 10.1016/S1473-3099(20)30132-8.", "ArticleIdList": ["10.1016/S1473-3099(20)30132-8", "PMC7158903", "32113509"]}, {"Citation": "Sumithira P., Mangala S., Sophie A., Latha C. Antiviral and antioxidant activities of two medicinal plants. Int J Curr Sci. 2012;256:261."}, {"Citation": "Tabuti J.R., Lye K.A., Dhillion S. Traditional herbal drugs of Bulamogi, Uganda: plants, use and administration. J. Ethnopharmacol. 2003;88:19\u201344. doi: 10.1016/S0378-8741(03)00161-2.", "ArticleIdList": ["10.1016/S0378-8741(03)00161-2", "12902048"]}, {"Citation": "Tai W., He L., Zhang X., Pu J., Voronin D., Jiang S., Zhou Y., Du L. Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine. Cell. Mol. Immunol. 2020:1\u20138. doi: 10.1038/s41423-020-0400-4.", "ArticleIdList": ["10.1038/s41423-020-0400-4", "PMC7091888", "32203189"]}, {"Citation": "Talbot P.J., \u00c9kand\u00e9 S., Cashman N.R., Mounir S., Stewart J.N. Neurotropism of human coronavirus 229E. Coronaviruses. 1994:339\u2013346.", "ArticleIdList": ["8209751"]}, {"Citation": "Tan E.L., Ooi E.E., Lin C.Y., Tan H.C., Ling A.E., Lim B., Stanton L.W. Inhibition of SARS coronavirus infection in vitro with clinically approved antiviral drugs. Emerg. Infect. Dis. 2004;10:581. doi: 10.3201/eid1004.030458.", "ArticleIdList": ["10.3201/eid1004.030458", "PMC3323075", "15200845"]}, {"Citation": "Thayil Seema M., Thyagarajan S. Methanol and aqueous extracts of Ocimum kilimandscharicum (Karpuratulasi) inhibits HIV-1 reverse transcriptase in vitro. Int. J. Pharmacogn. Phytochem. Res. 2016;8:1099\u20131103."}, {"Citation": "Tiwari B.K., Khosa R.L. Hepatoprotective and antioxidant effect of Sphaeranthus indicus against acetaminophen-induced hepatotoxicity in rats. J. Pharm. Sci. Res. 2009;1:26\u201330."}, {"Citation": "Tsai Y.C., Lee C.L., Yen H.R., Chang Y.S., Lin Y.P., Huang S.H., Lin C.W. Antiviral action of Tryptanthrin isolated from Strobilanthes cusia leaf against human coronavirus NL63. Biomolecules. 2020;10:366. doi: 10.3390/biom10030366.", "ArticleIdList": ["10.3390/biom10030366", "PMC7175275", "32120929"]}, {"Citation": "Vimalanathan S., Ignacimuthu S., Hudson J. Medicinal plants of Tamil Nadu (southern India) are a rich source of antiviral activities. Pharm. Biol. 2009;47:422\u2013429. doi: 10.1080/13880200902800196.", "ArticleIdList": ["10.1080/13880200902800196"]}, {"Citation": "Vincent M.J., Bergeron E., Benjannet S., Erickson B.R., Rollin P.E., Ksiazek T.G., Seidah N.G., Nichol S.T. Chloroquine is a potent inhibitor of SARS coronavirus infection and spread. Virol. J. 2005;2:69. doi: 10.1186/1743-422X-2-69.", "ArticleIdList": ["10.1186/1743-422X-2-69", "PMC1232869", "16115318"]}, {"Citation": "Walker L.M., Burton D.R. Passive immunotherapy of viral infections: \u2018super-antibodies\u2019 enter the fray. Nat. Rev. Immunol. 2018;18:297. doi: 10.1038/nri.2017.148.", "ArticleIdList": ["10.1038/nri.2017.148", "PMC5918154", "29379211"]}, {"Citation": "Walls A.C., Park Y.J., Tortorici M.A., Wall A., McGuire A.T., Veesler D. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell. 2020 doi: 10.1016/j.cell.2020.02.058. S0092-8674(20)30262-2.", "ArticleIdList": ["10.1016/j.cell.2020.02.058", "PMC7102599", "32155444"]}, {"Citation": "Wan Y., Shang J., Graham R., Baric R.S., Li F. Receptor recognition by novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS. J. Virol. 2020 doi: 10.1128/JVI.00127-20.", "ArticleIdList": ["10.1128/JVI.00127-20", "PMC7081895", "31996437"]}, {"Citation": "Wang J. 2020. Fast Identification of Possible Drug Treatment of Coronavirus Disease-19 (COVID-19) through Computational Drug Repurposing Study. ChemRxiv.", "ArticleIdList": ["10.26434/chemrxiv.11875446.v1", "PMC7197972", "32315171"]}, {"Citation": "Wang L., Wang Y., Ye D., Liu Q. A review of the 2019 novel coronavirus (COVID-19) based on current evidence. Int. J. Antimicrob. Agents. 2020:105948. doi: 10.1016/j.ijantimicag.2020.105948.", "ArticleIdList": ["10.1016/j.ijantimicag.2020.105948", "PMC7156162", "32201353"]}, {"Citation": "Wang D., Hu B., Hu C., Zhu F., Liu X., Zhang J., Wang B., Xiang H., Cheng Z., Xiong Y. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus\u2013infected pneumonia in Wuhan, China. Jama. 2020;323:1061\u20131069. doi: 10.1001/jama.2020.1585.", "ArticleIdList": ["10.1001/jama.2020.1585", "PMC7042881", "32031570"]}, {"Citation": "Wang M., Cao R., Zhang L., Yang X., Liu J., Xu M., Shi Z., Hu Z., Zhong W., Xiao G. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020:1\u20133. doi: 10.1038/s41422-020-0282-0.", "ArticleIdList": ["10.1038/s41422-020-0282-0", "PMC7054408", "32020029"]}, {"Citation": "Warren T.K., Jordan R., Lo M.K., Ray A.S., Mackman R.L., Soloveva V., Siegel D., Perron M., Bannister R., Hui H.C. Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys. Nature. 2016;531:381\u2013385. doi: 10.1038/nature17180.", "ArticleIdList": ["10.1038/nature17180", "PMC5551389", "26934220"]}, {"Citation": "World Health Organization (WHO) Laboratory testing of 2019 novel coronavirus (2019-nCoV) in suspected human cases. 2020. https://apps.who.int/iris/handle/10665/330676"}, {"Citation": "World Health Organization (WHO) Novel coronavirus (2019-nCoV) situation report. 2020. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports"}, {"Citation": "World Health Organization (WHO) Middle East respiratory syndrome coronavirus (MERS-CoV) \u2013 the Kingdom of Saudi Arabia. 2020. https://www.who.int/csr/don/24-february-2020-mers-saudi-arabia/en/"}, {"Citation": "World Health Organization (WHO) Surveillance case definitions for human infection with novel coronavirus (nCoV) 2020. https://apps.who.int/iris/handle/10665/330376"}, {"Citation": "Wu Z., McGoogan J.M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020 doi: 10.1001/jama.2020.2648.", "ArticleIdList": ["10.1001/jama.2020.2648", "32091533"]}, {"Citation": "Wu A., Peng Y., Huang B., Ding X., Wang X., Niu P., Meng J., Zhu Z., Zhang Z., Wang J. Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China. Cell Host Microbe. 2020;27:325\u2013328. doi: 10.1016/j.chom.2020.02.001.", "ArticleIdList": ["10.1016/j.chom.2020.02.001", "PMC7154514", "32035028"]}, {"Citation": "Wu C., Liu Y., Yang Y., Zhang P., Zhong W., Wang Y., Wang Q., Xu Y., Li M., Li X. Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. Acta Pharm. Sin. B. 2020 doi: 10.1016/j.apsb.2020.02.008.", "ArticleIdList": ["10.1016/j.apsb.2020.02.008", "PMC7102550", "32292689"]}, {"Citation": "Xu Y. Unveiling the origin and transmission of 2019-nCoV. Trends Microbiol. 2020;28:239\u2013240. doi: 10.1016/j.tim.2020.02.001.", "ArticleIdList": ["10.1016/j.tim.2020.02.001", "PMC7126210", "32155431"]}, {"Citation": "Xu J., Zhao S., Teng T., Abdalla A.E., Zhu W., Xie L., Wang Y., Guo X. Systematic comparison of two animal-to-human transmitted human coronaviruses: SARS-CoV-2 and SARS-CoV. Viruses. 2020;12:244. doi: 10.3390/v12020244.", "ArticleIdList": ["10.3390/v12020244", "PMC7077191", "32098422"]}, {"Citation": "Xu X., Yu C., Qu J., Zhang L., Jiang S., Huang D., Chen B., Zhang Z., Guan W., Ling Z. Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2. Eur. J. Nucl. Med. and Mol. Imaging. 2020:1\u20136. doi: 10.1007/s00259-020-04735-9.", "ArticleIdList": ["10.1007/s00259-020-04735-9", "PMC7080117", "32107577"]}, {"Citation": "Yan Y., Zou Z., Sun Y., Li X., Xu K.-F., Wei Y., Jin N., Jiang C. Anti-malaria drug chloroquine is highly effective in treating avian influenza A H5N1 virus infection in an animal model. Cell Res. 2013;23:300\u2013302. doi: 10.1038/cr.2012.165.", "ArticleIdList": ["10.1038/cr.2012.165", "PMC3567830", "23208422"]}, {"Citation": "Yang Y., Xiong Z., Zhang S., Yan Y., Nguyen J., Ng B., Lu H., Brendese J., Yang F., Wang H. Bcl-xL inhibits T-cell apoptosis induced by expression of SARS coronavirus E protein in the absence of growth factors. Biochem. J. 2005;392:135\u2013143. doi: 10.1042/BJ20050698.", "ArticleIdList": ["10.1042/BJ20050698", "PMC1317672", "16048439"]}, {"Citation": "Yao T.T., Qian J.D., Zhu W.Y., Wang Y., Wang G.Q. A systematic review of lopinavir therapy for SARS coronavirus and MERS coronavirus-A possible reference for coronavirus disease-19 treatment option. J. Med. Virol. 2020 doi: 10.1002/jmv.25729.", "ArticleIdList": ["10.1002/jmv.25729", "PMC7217143", "32104907"]}, {"Citation": "Yarnell E. Herbs for viral respiratory infections. Altern. Complement. Ther. 2018;24:35\u201343. doi: 10.1089/act.2017.29150.eya.", "ArticleIdList": ["10.1089/act.2017.29150.eya"]}, {"Citation": "Yin Y., Wunderink R.G. MERS, SARS and other coronaviruses as causes of pneumonia. Respirology. 2018;23:130\u2013137. doi: 10.1111/resp.13196.", "ArticleIdList": ["10.1111/resp.13196", "PMC7169239", "29052924"]}, {"Citation": "Youngchang K., Robert J., Natalia M., Michael E., Adam G., Karolina M., Andrzej J. 2020. Crystal Structure of Nsp15 Endoribonuclease NendoU from SARS-CoV-2. bioRxiv; p. 968388.", "ArticleIdList": ["10.1101/2020.03.02.968388"]}, {"Citation": "Yu Y.-B. The extracts of Solanum nigrum L. for inhibitory effects on HIV-1 and its essential enzymes. Korean. J. Orient. Med. 2004;10:119\u2013126."}, {"Citation": "Yuan H., Ma Q., Ye L., Piao G. The traditional medicine and modern medicine from natural products. Molecules. 2016;21:559. doi: 10.3390/molecules21050559.", "ArticleIdList": ["10.3390/molecules21050559", "PMC6273146", "27136524"]}, {"Citation": "Zaki A.M., Van Boheemen S., Bestebroer T.M., Osterhaus A.D., Fouchier R.A. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N. Engl. J. Med. 2012;367:1814\u20131820. doi: 10.1056/NEJMoa1211721.", "ArticleIdList": ["10.1056/NEJMoa1211721", "23075143"]}, {"Citation": "Zhang L., Lin D., Sun X., Curth U., Drosten C., Sauerhering L., Becker S., Rox K., Hilgenfeld R. Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved \u03b1-ketoamide inhibitors. Science. 2020:eabb3405. doi: 10.1126/science.abb3405.", "ArticleIdList": ["10.1126/science.abb3405", "PMC7164518", "32198291"]}, {"Citation": "Zhao Y., Zhao Z., Wang Y., Zhou Y., Ma Y., Zuo W. Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov. BioRxiv. 2020 doi: 10.1101/2020.01.26.919985.", "ArticleIdList": ["10.1101/2020.01.26.919985", "PMC7462411", "32663409"]}, {"Citation": "Zheng M., Song L. Novel antibody epitopes dominate the antigenicity of spike glycoprotein in SARS-CoV-2 compared to SARS-CoV. Cell. Mol. Immunol. 2020;17:1\u20133. doi: 10.1038/s41423-020-0385-z.", "ArticleIdList": ["10.1038/s41423-020-0385-z", "PMC7091851", "32132669"]}, {"Citation": "Zheng Y., Ma Y., Zhang J., Xie X. COVID-19 and the cardiovascular system. Nat. Rev. Cardiol. 2020 doi: 10.1038/s41569-020-0360-5.", "ArticleIdList": ["10.1038/s41569-020-0360-5", "PMC7095524", "32139904"]}, {"Citation": "Zhou X., Huang F., Xu L., Lin Z., de Vrij F., Ayo-Martin A.C., van der Kroeg M., Zhao M., Yin Y., Wang W. Hepatitis E virus infects neurons and brains. J. Infect. Dis. 2017;215:1197\u20131206. doi: 10.1093/infdis/jix079.", "ArticleIdList": ["10.1093/infdis/jix079", "28199701"]}, {"Citation": "Zumla A., Chan J.F., Azhar E.I., Hui D.S., Yuen K.Y. Coronaviruses\u2014drug discovery and therapeutic options. Nat. Rev. Drug Discov. 2016;15:327. doi: 10.1038/nrd.2015.37.", "ArticleIdList": ["10.1038/nrd.2015.37", "PMC7097181", "26868298"]}, {"Citation": "Zumla A., Hui D.S., Azhar E.I., Memish Z.A., Maeurer M. Reducing mortality from 2019-nCoV: host-directed therapies should be an option. Lancet. 2020;395:35\u201336. doi: 10.1016/S0140-6736(20)30305-6.", "ArticleIdList": ["10.1016/S0140-6736(20)30305-6", "PMC7133595", "32035018"]}]}], "History": [{"Year": "2020", "Month": "3", "Day": "9"}, {"Year": "2020", "Month": "3", "Day": "26"}, {"Year": "2020", "Month": "3", "Day": "26"}, {"Year": "2020", "Month": "4", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "6", "Day": "2", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "4", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "4", "Day": "4"}], "PublicationStatus": "ppublish", "ArticleIdList": ["32278175", "PMC7128376", "10.1016/j.scitotenv.2020.138277", "S0048-9697(20)31790-3"]}}]}